Press releases

29 Apr 2022

Ministry of Health, Malaysia and Drugs for Neglected Diseases initiative combine forces to lead the battle against dengue

Press releases

20 Apr 2022

DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue

Press releases

8 Apr 2022

Government of the Principality of Monaco supports DNDi to increase access to improved treatment for children with HIV

Press releases

15 Mar 2022

Pfizer blocking research to generate evidence on optimal use of novel antiviral for COVID-19 patients in low- and middle-income countries

Press releases

28 Feb 2022

ANTICOV trial finds drug combination nitazoxanide + ciclesonide does not reduce risk of hospitalization in COVID-19 outpatients

Press releases

25 Feb 2022

Expert consortium begins study in South Africa to develop an optimized treatment for cryptococcal meningitis

Press releases

10 Feb 2022

ANTICOV: clinical trial for COVID-19 in low-resource settings to test a new combination treatment

Press releases

26 Jan 2022

New global research partnership to find treatment for dengue – DNDi

Press releases

13 Jan 2022

Germany’s Federal Ministry of Education and Research (BMBF) grants additional funding to six PDPs fighting poverty-related and neglected tropical diseases

Press releases

4 Nov 2021

GHIT Fund expands support for DNDi Chagas disease drug discovery programmes

Press releases

27 Sep 2021

COVID Moonshot funded by COVID-19 Therapeutics Accelerator to rapidly develop a safe, globally accessible and affordable antiviral pill

Press releases

30 Aug 2021

Chagas: new study puts researchers closer to shortening the length of treatment

Press releases

5 Aug 2021

New DNDi report: International community must not repeat mistakes that have led to COVID-19 vaccine inequality by restricting access to new treatments for COVID-19

Press releases

27 Jul 2021

Malaysia continues national journey to battle hepatitis C with global partners

Press releases

27 Jul 2021

Launch of public health partnership to tackle the silent epidemic of hepatitis C in low- and middle-income countries

Press releases

19 Jul 2021

US FDA approves fexinidazole as the first all-oral treatment for sleeping sickness